Data from gene expression profiling have indexed six key genes (NOB1, DDX47, IGSF2, LTB4R, SCARB1, and SLC25A3) which have been suggested to discriminate the initial and late stages of each clinical phase of CML [45], but their role in the progression of CML remains unknown. Here, DDX47 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.